Abingdon Historical Income Statement

ABDX Stock

7.25 0.50 6.45%

Historical analysis of Abingdon Health income statement accounts such as Interest Expense of 0.0, Selling General Administrative of 3.5 M or Total Revenue of 1.4 M can show how well Abingdon Health Plc performed in making a profits. Evaluating Abingdon Health income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Abingdon Health's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Abingdon Health Plc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Abingdon Health Plc is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abingdon Health Plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Abingdon Income Statement Analysis

Abingdon Health Plc Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Abingdon Health shareholders. The income statement also shows Abingdon investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Abingdon Health Income Statement Chart

At this time, Abingdon Health's Depreciation And Amortization is comparatively stable compared to the past year. Other Operating Expenses is likely to gain to about 10.5 M in 2024, whereas Interest Income is likely to drop slightly above 678.8 K in 2024.

Tax Provision Selling General Administrative Total Revenue Cost Of Revenue Other Operating Expenses

Tax Provision

The amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities.

Total Revenue

Total revenue comprises all receipts Abingdon Health Plc generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Cost Of Revenue

Cost of Revenue is found on Abingdon Health Plc income statement and represents the costs associated with goods and services Abingdon Health provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Abingdon Health Plc. It is also known as Abingdon Health overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Most accounts from Abingdon Health's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Abingdon Health Plc current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abingdon Health Plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2021	2022	2023	2024 (projected)
Other Operating Expenses	14.9M	7.9M	7.5M	10.5M
Depreciation And Amortization	1.6M	673K	426K	793.0K

Other Operating Expenses Depreciation And Amortization

Abingdon Health income statement Correlations

	Tax Provision	Interest Income	Interest Expense	Selling General Administrative	Total Revenue	Gross Profit	Operating Income	Cost Of Revenue	Income Before Tax	Net Income	Depreciation And Amortization	Other Operating Expenses	Ebit	Research Development	Ebitda	Total Operating Expenses	Total Other Income Expense Net	Income Tax Expense	Net Interest Income	Net Income From Continuing Ops	Reconciled Depreciation	Selling And Marketing Expenses
Tax Provision		-0.72	-0.6	-0.19	0.66	0.25	0.15	0.48	-0.41	-0.43	-0.05	0.41	-0.56	0.56	-0.57	0.24	-0.71	0.7	-0.59	-0.26	0.28	0.53
Interest Income	-0.72		0.98	0.54	-0.43	0.04	-0.14	-0.47	0.73	0.74	-0.13	-0.44	0.78	-0.18	0.79	-0.06	0.91	-0.78	0.26	0.48	-0.47	-0.28
Interest Expense	-0.6	0.98		0.6	-0.39	0.0	-0.21	-0.4	0.69	0.7	-0.09	-0.39	0.71	-0.12	0.72	-0.03	0.87	-0.76	0.18	0.42	-0.4	-0.24
Selling General Administrative	-0.19	0.54	0.6		0.27	-0.22	-0.7	0.46	0.05	0.06	0.39	0.39	0.04	-0.13	0.06	0.42	0.39	-0.49	-0.4	-0.23	0.02	0.38
Total Revenue	0.66	-0.43	-0.39	0.27		0.43	0.03	0.68	-0.27	-0.29	-0.06	0.64	-0.41	0.46	-0.42	0.53	-0.52	0.61	-0.79	-0.22	0.08	0.87
Gross Profit	0.25	0.04	0.0	-0.22	0.43		0.84	-0.37	0.62	0.6	-0.85	-0.28	0.47	0.51	0.45	0.02	-0.03	0.42	-0.1	0.74	-0.65	0.26
Operating Income	0.15	-0.14	-0.21	-0.7	0.03	0.84		-0.64	0.53	0.52	-0.87	-0.55	0.43	0.36	0.41	-0.31	-0.12	0.46	0.28	0.75	-0.55	-0.15
Cost Of Revenue	0.48	-0.47	-0.4	0.46	0.68	-0.37	-0.64		-0.78	-0.79	0.63	0.89	-0.8	0.06	-0.79	0.52	-0.51	0.29	-0.73	-0.83	0.61	0.68
Income Before Tax	-0.41	0.73	0.69	0.05	-0.27	0.62	0.53	-0.78		1.0	-0.76	-0.73	0.94	0.02	0.94	-0.3	0.65	-0.34	0.36	0.94	-0.86	-0.24
Net Income	-0.43	0.74	0.7	0.06	-0.29	0.6	0.52	-0.79	1.0		-0.74	-0.73	0.95	0.0	0.94	-0.3	0.67	-0.37	0.37	0.93	-0.86	-0.25
Depreciation And Amortization	-0.05	-0.13	-0.09	0.39	-0.06	-0.85	-0.87	0.63	-0.76	-0.74		0.67	-0.62	-0.15	-0.6	0.47	-0.1	-0.22	-0.23	-0.88	0.8	0.05
Other Operating Expenses	0.41	-0.44	-0.39	0.39	0.64	-0.28	-0.55	0.89	-0.73	-0.73	0.67		-0.71	0.2	-0.7	0.79	-0.47	0.34	-0.74	-0.74	0.55	0.72
Ebit	-0.56	0.78	0.71	0.04	-0.41	0.47	0.43	-0.8	0.94	0.95	-0.62	-0.71		-0.05	1.0	-0.25	0.82	-0.53	0.37	0.9	-0.84	-0.29
Research Development	0.56	-0.18	-0.12	-0.13	0.46	0.51	0.36	0.06	0.02	0.0	-0.15	0.2	-0.05		-0.05	0.54	-0.16	0.45	-0.5	0.08	0.17	0.31
Ebitda	-0.57	0.79	0.72	0.06	-0.42	0.45	0.41	-0.79	0.94	0.94	-0.6	-0.7	1.0	-0.05		-0.24	0.83	-0.56	0.37	0.89	-0.82	-0.29
Total Operating Expenses	0.24	-0.06	-0.03	0.42	0.53	0.02	-0.31	0.52	-0.3	-0.3	0.47	0.79	-0.25	0.54	-0.24		-0.06	0.14	-0.69	-0.35	0.3	0.62
Total Other Income Expense Net	-0.71	0.91	0.87	0.39	-0.52	-0.03	-0.12	-0.51	0.65	0.67	-0.1	-0.47	0.82	-0.16	0.83	-0.06		-0.88	0.24	0.49	-0.46	-0.31
Income Tax Expense	0.7	-0.78	-0.76	-0.49	0.61	0.42	0.46	0.29	-0.34	-0.37	-0.22	0.34	-0.53	0.45	-0.56	0.14	-0.88		-0.32	-0.16	0.21	0.39
Net Interest Income	-0.59	0.26	0.18	-0.4	-0.79	-0.1	0.28	-0.73	0.36	0.37	-0.23	-0.74	0.37	-0.5	0.37	-0.69	0.24	-0.32		0.36	-0.21	-0.92
Net Income From Continuing Ops	-0.26	0.48	0.42	-0.23	-0.22	0.74	0.75	-0.83	0.94	0.93	-0.88	-0.74	0.9	0.08	0.89	-0.35	0.49	-0.16	0.36		-0.91	-0.2
Reconciled Depreciation	0.28	-0.47	-0.4	0.02	0.08	-0.65	-0.55	0.61	-0.86	-0.86	0.8	0.55	-0.84	0.17	-0.82	0.3	-0.46	0.21	-0.21	-0.91		-0.05
Selling And Marketing Expenses	0.53	-0.28	-0.24	0.38	0.87	0.26	-0.15	0.68	-0.24	-0.25	0.05	0.72	-0.29	0.31	-0.29	0.62	-0.31	0.39	-0.92	-0.2	-0.05

Click cells to compare fundamentals

Abingdon Health Account Relationship Matchups

Abingdon Health income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Tax Provision	(154.3K)	(1.1K)	19K	(331K)	(105K)	(465.3K)
Interest Income	3.5K	1.6K	234K	4K	89K	678.8K
Interest Expense	22.4K	64.3K	234K	69K	72K	57K
Selling General Administrative	3.0M	3.4M	7.5M	6.6M	5.2M	5.1M
Total Revenue	2.3M	5.2M	11.6M	2.8M	4.0M	6.1M
Gross Profit	1.6M	4.1M	3.4M	(5.2M)	1.4M	3.7M
Operating Income	(1.4M)	217K	(5.5M)	(12.1M)	(3.8M)	(1.4M)
Cost Of Revenue	705.4K	1.1M	8.2M	8.1M	2.6M	2.5M
Income Before Tax	(1.4M)	(3.4M)	(7.1M)	(21.7M)	(3.8M)	(1.4M)
Net Income Applicable To Common Shares	(1.3M)	(3.4M)	(7.0M)	(21.3M)	(3.5M)	(3.3M)
Net Income	(1.3M)	(3.4M)	(7.0M)	(21.3M)	(3.5M)	(1.3M)
Depreciation And Amortization	591.7K	749K	1.6M	673K	426K	793.0K
Other Operating Expenses	8.5M	17.1M	14.9M	7.9M	7.5M	10.5M
Ebit	(3.4M)	(6.8M)	(21.6M)	(3.5M)	(1.3M)	(1.4M)
Research Development	210.7K	854K	503K	182K	209.3K	198.8K
Ebitda	(2.8M)	(6.1M)	(20.0M)	(2.8M)	(916K)	(961.8K)
Total Operating Expenses	7.4M	8.9M	6.9M	5.2M	5.1M	6.7M
Total Other Income Expense Net	(63K)	(234K)	(65K)	14K	(26K)	(24.7K)
Income Tax Expense	1K	(81K)	(423K)	(355K)	(128K)	(134.4K)
Net Interest Income	(62.7K)	(234K)	(65K)	17K	19.6K	20.5K
Net Income From Continuing Ops	(3.4M)	(7.0M)	(21.3M)	(3.5M)	(3.1M)	(3.3M)
Reconciled Depreciation	4.1M	749K	8.8M	759K	872.9K	829.2K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

Additional Tools for Abingdon Stock Analysis

When running Abingdon Health's price analysis, check to measure Abingdon Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abingdon Health is operating at the current time. Most of Abingdon Health's value examination focuses on studying past and present price action to predict the probability of Abingdon Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abingdon Health's price. Additionally, you may evaluate how the addition of Abingdon Health to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC